The relationship between the bladder volume and optimal treatment planning in definitive radiotherapy for localized prostate cancer

References

• De Meerleer GO, Villeirs GM, Vakaet L, Delrue LJ, De Neve WJ. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer. Strahlenther Onkol 2004;180:573–81.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109–22.
   PubMed Web of Science ®Google Scholar
• Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31: 1257–80.
   PubMed Web of Science ®Google Scholar
• Brierley JD, Cummings BJ, Wong CS, McLean M, Cashell A, Manter S. The variation of small bowel volume within the pelvis before and during adjuvant radiation for rectal cancer. Radiother Oncol 1994;31:110–6.
   PubMed Web of Science ®Google Scholar
• Kim TH, Chie EK, Kim DY, Park SY, Cho KH, Jung KH, . Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients. Int J Radiat Oncol Biol Phys 2005;62: 769–75.
   PubMed Web of Science ®Google Scholar
• Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003;69: 291–304.
   PubMed Web of Science ®Google Scholar
• Waldenstrom AC, Alsadius D, Pettersson N, Johansson KA, Holmberg E, Steineck G, . Variation in position and volume of organs at risk in the small pelvis. Acta Oncol 2010;49:491–9.
   PubMed Web of Science ®Google Scholar
• Stam MR, van Lin EN, van der Vight LP, Kaanders JH, Visser AG. Bladder filling variation during radiation treatment of prostate cancer: Can the use of a bladder ultrasound scanner and biofeedback optimize bladder filling? Int J Radiat Oncol Biol Phys 2006;65:371–7.
   PubMed Web of Science ®Google Scholar
• O'Doherty UM, McNair HA, Norman AR, Miles E, Hooper S, Davies M, . Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 2006;79:335–40.
   PubMed Web of Science ®Google Scholar
• Nakamura N, Shikama N, Takahashi O, Ito M, Hashimoto M, Uematsu M, . Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer. Strahlenther Onkol 2010;186:637–42.
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123–35.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, . Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on rtog 9406 dose levels I and II. Int J Radiat Oncol Biol Phys 2003;56:192–8.
   PubMed Web of Science ®Google Scholar
• Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635–42.
   PubMed Web of Science ®Google Scholar
• Harsolia A, Vargas C, Yan D, Brabbins D, Lockman D, Liang J, . Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys 2007; 69:1100–9.
   PubMed Web of Science ®Google Scholar
• Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, . Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007;67:1059–65.
   PubMed Web of Science ®Google Scholar
• Fonteyne V, Villeirs G, Lumen N, De Meerleer G. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol 2009;92:42–7.
   PubMed Web of Science ®Google Scholar
• Villeirs GM, De Meerleer GO, Verstraete KL, De Neve WJ. Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:1611–21.
   PubMed Web of Science ®Google Scholar